CollPlant Biotechnologies Ltd.
CLGN
$3.41
-$0.17-4.75%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 2.40M | 2.47M | 515.00K | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 2.40M | 2.47M | 515.00K | |
| Cost of Revenue | -- | 918.00K | 1.27M | 1.63M | |
| Gross Profit | -- | 1.48M | 1.20M | -1.11M | |
| SG&A Expenses | -- | 5.30M | 5.56M | 5.63M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 15.74M | 17.04M | 17.77M | |
| Operating Income | -- | -13.34M | -14.57M | -17.25M | |
| Income Before Tax | -- | -13.00M | -13.87M | -16.61M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -13.00 | -13.87 | -16.61 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -13.00M | -13.87M | -16.61M | |
| EBIT | -- | -13.34M | -14.57M | -17.25M | |
| EBITDA | -- | -12.37M | -13.57M | -16.21M | |
| EPS Basic | -- | -11.26 | -12.11 | -14.50 | |
| Normalized Basic EPS | -- | -3.88 | -4.41 | -4.41 | |
| EPS Diluted | -- | -11.26 | -12.11 | -14.50 | |
| Normalized Diluted EPS | -- | -3.88 | -4.41 | -4.41 | |
| Average Basic Shares Outstanding | -- | 4.62M | 4.58M | 4.58M | |
| Average Diluted Shares Outstanding | -- | 4.62M | 4.58M | 4.58M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |